Back to Companies
MADRIGAL PHARMACEUTICALS, INC.
MDGLNasdaqCIK: 0001157601
Recent Form 4 activity at MADRIGAL PHARMACEUTICALS, INC. (MDGL) spans 50 filings across 15 insiders (1 buying and 9 selling). Purchases total $61.9M against $168.9M in sales — net selling, for net sales of $107.0M. FRIEDMAN PAUL A (Director) is the most active by dollar volume, and the single largest transaction was $50.3M by FRIEDMAN PAUL A. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$268.0M
Purchases
$61.9M
Sales
$168.9M
Unique Insiders
15
Recent Insider Trades
50 loaded
| Aug 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | REED JOHN C | Director | Grant | $547.1K |
| Aug 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | REED JOHN C | Director | Other | $0 |
| Jul 20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO, Director | Sell | $1.4M |
| Jun 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Director | Grant | $382.9K |
| Jun 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Director | Grant | $382.9K |
| Jun 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Director | Grant | $382.9K |
| Jun 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Director | Grant | $382.9K |
| Jun 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Insider | Grant | $1.5M |
| Jun 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Brennan Daniel J. | Director | Grant | $340.4K |
| Jun 1 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Soergel David | Chief Medical Officer | Sell | $516.6K |
| May 22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Director | Sell | $2.9M |
| May 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Soergel David | Chief Medical Officer | Sell | $435.4K |
| Mar 6 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Director | Sell | $212.1K |
| Mar 6 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | General Counsel | Sell | $155.5K |
| Mar 6 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Soergel David | Chief Medical Officer | Grant | $2.4M |
| Mar 6 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Huntsman Carole | Chief Commercial Officer | Sell | $181.0K |
| Mar 6 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO, Director | Sell | $718.3K |
| Mar 2 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Dier Mardi | EVP and CFO | Sell | $505.4K |
| Feb 24 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Director | Exercise | $36.8K |
| Jan 26 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Huntsman Carole | Chief Commercial Officer | Sell | $449.3K |
| Jan 26 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO, Director | Sell | $776.5K |
| Jan 26 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Director | Sell | $318.6K |
| Jan 26 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S | Director | Exercise | $131.7K |
| Jan 20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Director | Sell | $1.1M |
| Jan 20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | General Counsel | Sell | $344.2K |
| Jan 20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Thakkar Rita | Chief Accounting Officer | Grant | $905.5K |
| Jan 20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Thakkar Rita | Chief Accounting Officer | Other | $0 |
| Jan 13 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Director | Sell | $9.6M |
| Jan 13 | MDGL MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Director | Sell | $154.3K |
| Jan 13 | MDGL MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Director | Sell | $12.8M |
| Jan 13 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Director | Sell | $132.1K |
| Dec 12 | MDGL MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Director | Sell | $13.7M |
| Dec 12 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Director | Sell | $10.3M |
| Dec 4 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO, Director | Sell | $1.4M |
| Dec 3 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Dier Mardi | EVP and CFO | Sell | $2.4M |
| Nov 21 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Huntsman Carole | Chief Commercial Officer | Sell | $1.1M |
| Nov 7 | MDGL MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Director | Sell | $8.0M |
| Aug 21 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John | President and CEO, Director | Sell | $3.0M |
| Aug 20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Insider | Buy | $25.0M |
| Aug 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Kelley Shannon T | General Counsel | Sell | $479.6K |
| Aug 20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Insider | Buy | $36.9M |
| Aug 15 | MDGL MADRIGAL PHARMACEUTICALS, INC. | BATE KENNETH | Director | Sell | $3.7M |
| Aug 13 | MDGL MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Director | Sell | $47.8M |
| Aug 13 | MDGL MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Director | Sell | $16.6M |
| Aug 13 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Director | Sell | $16.5M |
| Aug 5 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Brennan Daniel J. | Director | Other | $0 |
| Aug 5 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Brennan Daniel J. | Director | Grant | $515.2K |
| Jul 22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Director | Sell | $490.0K |
| Jul 22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Director | Sell | $350.0K |
| Jul 18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Director | Sell | $10.3M |
50 filings+